ArticleOncotarget2017

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports.

Yongmei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.